AuthorisedHuman Pharmacology (Phase I)- OtherInterventional

A PHASE 1B, MULTICENTER, RANDOMIZED, PLACEBO- CONTROLLED, DOUBLE-BLIND STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND BIOLOGICAL ACTIVITY OF TQS-168 IN SUBJECTS WITH AMYOTROPHIC LATERAL SCLEROSIS

At a glance

Status

Authorised

Phase

Human Pharmacology (Phase I)- Other

Sponsor

Tranquis Therapeutics Inc.

Enrolment target

Start

11 Oct 2023

Age 18 Years to any · Sex: All

Always speak to your GP or specialist before deciding to take part in a study.